Director Mary Fisher resigns from Dermata board, effective March 31, 2026

Dermata Therapeutics, Inc.

Resignation due to her employer being acquired; no longer permitted to serve on board.
No disagreement with company or management cited.
Board size to decrease from eight to seven after resignation effective.

item 5.02

Dermata Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-008037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.